Correlation Between Arcellx and NewAmsterdam Pharma
Can any of the company-specific risk be diversified away by investing in both Arcellx and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcellx and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcellx and NewAmsterdam Pharma, you can compare the effects of market volatilities on Arcellx and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcellx with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcellx and NewAmsterdam Pharma.
Diversification Opportunities for Arcellx and NewAmsterdam Pharma
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Arcellx and NewAmsterdam is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Arcellx and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and Arcellx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcellx are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of Arcellx i.e., Arcellx and NewAmsterdam Pharma go up and down completely randomly.
Pair Corralation between Arcellx and NewAmsterdam Pharma
Given the investment horizon of 90 days Arcellx is expected to generate 0.75 times more return on investment than NewAmsterdam Pharma. However, Arcellx is 1.33 times less risky than NewAmsterdam Pharma. It trades about 0.08 of its potential returns per unit of risk. NewAmsterdam Pharma is currently generating about 0.05 per unit of risk. If you would invest 4,069 in Arcellx on August 31, 2024 and sell it today you would earn a total of 4,738 from holding Arcellx or generate 116.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arcellx vs. NewAmsterdam Pharma
Performance |
| Timeline |
| Arcellx |
| NewAmsterdam Pharma |
Arcellx and NewAmsterdam Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arcellx and NewAmsterdam Pharma
The main advantage of trading using opposite Arcellx and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcellx position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.| Arcellx vs. Nuvalent | Arcellx vs. Ventyx Biosciences | Arcellx vs. Amylyx Pharmaceuticals | Arcellx vs. Day One Biopharmaceuticals |
| NewAmsterdam Pharma vs. Cue Biopharma | NewAmsterdam Pharma vs. Eliem Therapeutics | NewAmsterdam Pharma vs. Inhibrx | NewAmsterdam Pharma vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |